BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31652309)

  • 1. BCYRN1 is correlated with progression and prognosis in gastric cancer.
    Zhai H; Li Y
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31652309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of miR-335-5p by Long Noncoding RNA ZEB1-AS1 in Gastric Cancer Promotes Tumor Proliferation and Invasion.
    Zhang LL; Zhang LF; Guo XH; Zhang DZ; Yang F; Fan YY
    DNA Cell Biol; 2018 Jan; 37(1):46-52. PubMed ID: 29215918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA MRPL39 Inhibits Gastric Cancer Proliferation and Progression by Directly Targeting miR-130.
    Yu MJ; Zhao N; Shen H; Wang H
    Genet Test Mol Biomarkers; 2018 Nov; 22(11):656-663. PubMed ID: 30452299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA EGOT Promotes Tumorigenesis Via Hedgehog Pathway in Gastric Cancer.
    Peng W; Wu J; Fan H; Lu J; Feng J
    Pathol Oncol Res; 2019 Jul; 25(3):883-887. PubMed ID: 29209988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA PVT1 promotes the migration of gastric cancer by functioning as ceRNA of miR-30a and regulating Snail.
    Wang L; Xiao B; Yu T; Gong L; Wang Y; Zhang X; Zou Q; Zuo Q
    J Cell Physiol; 2021 Jan; 236(1):536-548. PubMed ID: 32557622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ELK1-induced upregulation of lncRNA TRPM2-AS promotes tumor progression in gastric cancer by regulating miR-195/ HMGA1 axis.
    Huang B; Chang C; Wang BL; Li H
    J Cell Biochem; 2019 Oct; 120(10):16921-16933. PubMed ID: 31104318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA SOX2OT contributes to gastric cancer progression by sponging miR-194-5p from AKT2.
    Qu F; Cao P
    Exp Cell Res; 2018 Aug; 369(2):187-196. PubMed ID: 29782828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOX transcript antisense intergenic RNA represses E-cadherin expression by binding to EZH2 in gastric cancer.
    Chen WM; Chen WD; Jiang XM; Jia XF; Wang HM; Zhang QJ; Shu YQ; Zhao HB
    World J Gastroenterol; 2017 Sep; 23(33):6100-6110. PubMed ID: 28970725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
    Min C; Zhang A; Qin J
    Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X; Wen W; Zhu D; Yan T; Cheng W; Huang Z; Zhang L; Zhang H; Wang T; Zhu W; Zhu Y; Zhu J
    PLoS One; 2017; 12(1):e0170298. PubMed ID: 28099468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-183-5p acts as a potential prognostic biomarker in gastric cancer and regulates cell functions by modulating EEF2.
    Li W; Cui X; Qi A; Yan L; Wang T; Li B
    Pathol Res Pract; 2019 Nov; 215(11):152636. PubMed ID: 31558304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
    Li J; Zou X
    Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA BCYRN1 promotes prostate cancer progression via elevation of HDAC11.
    Huo W; Qi F; Wang K
    Oncol Rep; 2020 Sep; 44(3):1233-1245. PubMed ID: 32705287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA MT1JP functions as a ceRNA in regulating FBXW7 through competitively binding to miR-92a-3p in gastric cancer.
    Zhang G; Li S; Lu J; Ge Y; Wang Q; Ma G; Zhao Q; Wu D; Gong W; Du M; Chu H; Wang M; Zhang A; Zhang Z
    Mol Cancer; 2018 May; 17(1):87. PubMed ID: 29720189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulation of long non-coding RNA PCAT-1 correlates with tumor progression and poor prognosis in gastric cancer.
    Cui WC; Wu YF; Qu HM
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3021-3027. PubMed ID: 28742205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00473 predicts poor prognosis and regulates cell migration and invasion in gastric cancer.
    Zhang W; Song Y
    Biomed Pharmacother; 2018 Nov; 107():1-6. PubMed ID: 30071345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00319 acts as a
    Zou J; Wu K; Lin C; Jie ZG
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G10-G22. PubMed ID: 31433213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X; Na H; Xu L; Zhang X; Feng Z; Zhou X; Cui J; Zhang J; Lin F; Yang S; Yue F; Mousa H; Zuo Y
    Biomed Pharmacother; 2020 Jan; 121():109644. PubMed ID: 31766099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.